Lesuride Tablet contains Levosulpiride 25 mg, a selective dopamine D2 receptor antagonist primarily used in the management of gastrointestinal motility disorders and certain psychiatric conditions. Levosulpiride exerts prokinetic effects by enhancing gastric emptying and improving esophageal motility, making it effective in treating functional dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying. Additionally, its central dopaminergic antagonism provides benefits in the treatment of schizophrenia, depression, and other mood disorders, often improving cognitive and emotional symptoms. Lesuride is generally well-tolerated, with common adverse effects including mild extrapyramidal symptoms, hyperprolactinemia, and gastrointestinal disturbances such as nausea or diarrhea. It is contraindicated in patients with hypersensitivity to sulpiride or other benzamide derivatives, and caution is advised in those with a history of seizures, renal or hepatic impairment. Dosage should be individualized based on the indication and patient response, with regular monitoring for side effects. Lesuride Tablet should be used under medical supervision, ensuring appropriate evaluation of therapeutic benefits versus potential risks. It is not recommended during pregnancy or lactation unless clearly necessary. Overall, Lesuride offers a valuable therapeutic option for managing both gastrointestinal and neuropsychiatric disorders.